Abdel-Ghani Mustafa Azzouqa MD

hematologist and oncologist

Summary

Dr. Abdel-Ghani Azzouqa is an oncologist based in Rapid City, SD, He completed his internal medicine residency at the Cleveland Clinic Foundation and a fellowship in hematology and medical oncology at the Mayo Clinic. Dr. Azzouqa has multiple publications, including studies on chemotherapy-induced neuropathy, therapeutic agents for lung cancer, and utilization characteristics of monoclonal antibodies in multiple myeloma. He has participated in various clinical trials, notably exploring chemotherapy, immunotherapy, and radiation therapy in cancer treatment. He has received several honors,inlcluding team work and WOW awards

Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2016 - 2019
Cleveland Clinic FoundationResidency, Internal Medicine, 2012 - 2016
Jordan University of Science and Technology FOMClass of 2011

PubMed

Journal Articles

Reducing Unplanned Medical Oncology Readmissions by Improving Outpatient Care Transitions: A Process Improvement Project at the Cleveland Clinic
Montero AJ, Stevenson J, Guthrie AE, Best C, Goodman LM, Shrotriya S, Azzouqa AG, Parala A, Lagman R, Bolwell BJ et al, J Oncol Pract, 1/1/2016

Abstracts/Posters

Association of CDKN2A gene alteration with high expression of PD-L1.
Zhang Y, Marin-Acevedo JA, Azzouqa AG, Manochakian R, Lou Y, Journal of Clinical Oncology, 1/1/2018
Gemcitabine in combination with Nab-Paclitaxel for treatment of recurrent ovarian cancer; The Mayo Clinic Florida experience.
Abdel-Ghani Azzouqa, Gerardo Colon-otero, 27th Annual Mayo Clinic Hem/Onc Reviews, Amelia Island, FL, 1/1/2018
Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma.
Ailawadhi S, Azzouqa A-G, Meghji Z, Jain T, Diehl N, Gebhardt SP, Shah V, Hodge DO, Patel R, Jani P et al, Blood, 1/1/2017
Survival Trends in Young Patients with Multiple Myeloma: Focus on Racial-Ethnic Minorities.
Ailawadhi S, Azzouqa A-G, Hodge DO, Cochuyt J, Meghji Z, Patel R, Jani P, Kakar TS, Aggarwal A, Sher T et al, Blood, 1/1/2017
Reducing Unplanned Medical Oncology Readmissions by Improving Outpatient Care Transitions: A Process Improvement Project at the Cleveland Clinic.
Montero AJ, Stevenson J, Guthrie AE, Best C, Goodman LM, Shrotriya S, Azzouqa A-G, Parala A, Lagman R, Bolwell BJ et al, Journal of Oncology Practice, 1/1/2016
Effect of improving guideline-based prophylactic growth factor (pGCSF) use with chemotherapy (CT) on the risk of febrile neutropenia (FN) in non-small cell lung cancer...
Goodman LM, Moeller M, Dalby CK, Azzouqa A, Guthrie AE, Earl MA, Velcheti V, Shapiro MA, Pennell NA, Stevenson J, Journal of Clinical Oncology, 1/1/2015
Join now to see all

Lectures

Impact of time to treatment initiation (TTI) on survival of patients with newly diagnosed non-small cell lung cancer (NSCLC).
2019 ASCO Annual Meeting - 6/1/2019
Secondary Acute pro myelocytic leukemia.
Amelia Island, FL - 1/1/2017
Biclonal leukemia.
Tampa, FL
Lung Cancer Biology, Diagnosis, Prognosis and Treatment
Jacksonville, FL
Thrombocytopenia, Deferential Diagnosis, and Management Strategies
Jacksonville, FL
Molecular Biology Introduction
Jacksonville, FL
Join now to see all